Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year revenue growth rate
5Y CAGR
+11.5%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 129.51% |
| Q3 2025 | -46.57% |
| Q2 2025 | 341.75% |
| Q1 2025 | -60.24% |
| Q4 2024 | -58.46% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | -36.78% |
| Q4 2023 | 24.73% |
| Q3 2023 | 25.00% |
| Q2 2023 | 23.12% |
| Q1 2023 | -24.26% |
| Q4 2022 | -21.45% |
| Q3 2022 | -28.94% |
| Q2 2022 | 52.35% |
| Q1 2022 | 24.97% |
| Q4 2021 | -20.94% |
| Q3 2021 | 7.11% |
| Q2 2021 | 9.57% |
| Q1 2021 | 111.51% |
| Q4 2020 | 75.00% |
| Q3 2020 | 829.03% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | -47.37% |
| Q3 2017 | 35.71% |
| Q2 2017 | -3.45% |
| Q1 2017 | 31.82% |
| Q4 2016 | -24.14% |
| Q3 2016 | -71.84% |
| Q2 2016 | -2.83% |
| Q1 2016 | -17.19% |